Mengdi Pharmaceuticals China business bidding hot!

Finishingrainbow

A few days ago, according to Reuters, citing two people familiar with the matter, Mundipharma has included Boyu Capital and Sinopharm on the list of bidders for its business in China
.

In addition, Chinese mergers and acquisitions companies CITIC Capital (CITIC Capital) and CITIC Industry Fund (CPE) are also on the bidding candidates list
.

One of the people familiar with the matter said that Mundi Pharmaceuticals has screened out about half of about 20 initial potential buyers to enter the next round, including private equity companies and strategic investors
.

Reuters reported that the offer for the second round of bidding is non-binding and will be conducted in July
.

It is reported that at the same time that Mengdi sold its Chinese business, its owner, the Sackler family, proposed a $4.
3 billion settlement agreement to resolve the opioid lawsuits Purdue Pharmaceuticals faces in the United States
.

Both Mundi Pharmaceuticals and Purdue Pharmaceuticals are owned by the Sackler family
.

According to data, Purdue Pharmaceuticals has been investigated by US officials for a painkiller called OxyContin
.

At present, the case has become a landmark case in the United States trying to control the abuse of opioids.